PREVENTION OF STEROID-INDUCED OSTEOPOROSIS WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (APD)

This publication has 29 references indexed in Scilit:

• The Pathomechanics of Osteoporoses
  Clinical Orthopaedics and Related Research, 1985
• Quantitative computed tomography for prediction of vertebral fracture risk
  Bone, 1985
• The Effects of Dichloromethylene Biphosphonate on Osteoporotic Femora of Adult Castrate Male Rats
  Cells Tissues Organs, 1985
• EFFECTIVE ORAL TREATMENT OF SEVERE PAGET'S DISEASE OF BONE WITH APD (3‐AMINO‐I‐HYDROXYPROPYLIDENE‐1,1‐BISPHOSPHONATE); A COMPARISON WITH COMBINED CALCITONIN + EHDP (1 ‐HYDROXYETHYLIDENE‐1,1 ‐BISPHOSPHONATE)
  Australian and New Zealand Journal of Medicine, 1984
• Tight jeans as a compression garment after major trauma.
  BMJ, 1984
• Steroid-Induced Fractures and Bone Loss in Patients with Asthma
  New England Journal of Medicine, 1983
• CORTICOSTEROID‐INDUCED OSTEOPENIA AND VITAMIN D METABOLISM. EFFECT OF VITAMIN D₂, CALCIUM PHOSPHATE AND SODIUM FLUORIDE ADMINISTRATION
  Clinical Endocrinology, 1982
• Effect of Dichloromethane Diphosphonate on Cortisol-Induced Bone Loss in Young Adult Rabbits
  Published by Wolters Kluwer Health ,1981
• Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration.
  Journal of Clinical Investigation, 1979
• TREATMENT OF PAGET'S DISEASE WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)
  The Lancet, 1979